Next Article in Journal
Cardiac Imaging in RASopathies/Mitogen Activated Protein Kinase Syndromes
Previous Article in Journal
Imaging in Rare Disease: A Roadmap for Diagnosis
 
 
Cardiogenetics is published by MDPI from Volume 10 Issue 2 (2020). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Cardiovascular Magnetic Resonance in Rare Systemic Diseases

by
Antonello D’Andrea
1,*,
Marianna Fontana
2,
Rosangela Cocchia
1,
Raffaele Calabrò
1,
Maria Giovanna Russo
1 and
James C. Moon
2,3
1
Monaldi Hospital, Second University of Naples, AORN Ospedali dei Colli, 80122 Naples, Italy
2
Heart Hospital Imaging Centre, Heart Hospital, London, UK
3
Institute of Cardiovascular Sciences, UCL, London, UK
*
Author to whom correspondence should be addressed.
Cardiogenetics 2013, 3(1), e8; https://doi.org/10.4081/cardiogenetics.2013.e8
Submission received: 20 May 2013 / Revised: 10 October 2013 / Accepted: 11 October 2013 / Published: 24 December 2013

Abstract

The heart may be involved in a number of systemic syndromes. The pericardium, myocardium, heart valves, and coronary arteries may be involved either singly or in various combinations. In most cases the cardiac manifestations are not the dominant feature, but in some it is the primary determinant of symptoms and survival. Both the early identification of cardiac involvement and the etiology underneath is of paramount importance, as some causes require specific treatment and may be correctable. In this respect non-invasive imaging plays a central role especially in the context of rare cardiac disease, where specific imaging features can help to make the appropriate diagnosis on a substantial proportion of them, enabling the physician to choose the best management strategy tailored to the disease. Whereas echocardiography is the firstline investigation for detecting a cardiac involvement in systemic disease, cardiovascular magnetic resonance (CMR) provides additional incremental data allowing in addition to a detailed examination of cardiac structure and function also the tissue characterization. The aim of this review is therefore to delineate the role of CMR in detecting cardiac involvement in patients with rare systemic diseases and delineate the specific imaging features of the different etiologies.
Keywords: cardiovascular magnetic resonance; rare systemic diseases; tissue characterization cardiovascular magnetic resonance; rare systemic diseases; tissue characterization

Share and Cite

MDPI and ACS Style

D’Andrea, A.; Fontana, M.; Cocchia, R.; Calabrò, R.; Russo, M.G.; Moon, J.C. Cardiovascular Magnetic Resonance in Rare Systemic Diseases. Cardiogenetics 2013, 3, e8. https://doi.org/10.4081/cardiogenetics.2013.e8

AMA Style

D’Andrea A, Fontana M, Cocchia R, Calabrò R, Russo MG, Moon JC. Cardiovascular Magnetic Resonance in Rare Systemic Diseases. Cardiogenetics. 2013; 3(1):e8. https://doi.org/10.4081/cardiogenetics.2013.e8

Chicago/Turabian Style

D’Andrea, Antonello, Marianna Fontana, Rosangela Cocchia, Raffaele Calabrò, Maria Giovanna Russo, and James C. Moon. 2013. "Cardiovascular Magnetic Resonance in Rare Systemic Diseases" Cardiogenetics 3, no. 1: e8. https://doi.org/10.4081/cardiogenetics.2013.e8

Article Metrics

Back to TopTop